JIMD Podcasts cover art

All Episodes

JIMD Podcasts — 266 episodes

#
Title
1

High Glycine, Different Diagnoses

2

IMD Research Round-Up: Homocystinuria

3

Revisiting D-Bifunctional Protein Deficiency

4

Metabolic Mysteries: Two adult siblings with liver disease and haematological abnormalities

5

The Grey Zone in ABCD1 Variant Classification

6

Metabolic Mysteries: A 57-year-old man with vomiting and worsening confusion

7

Metabolic Mysteries: Recurrent abdominal pain, “FMF” and attacks around menstruation

8

Tyrosine Hydroxylase Deficiency: Consensus guidelines

9

Shortcast: Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency

10

D-Glyceric aciduria: is GLYCTK really mitochondrial?

11

Shortcast: Drivers of Diagnostic Delay in Mito Disease: Missed Recognition of Canonical Features

12

mRNA therapies in liver Inherited Metabolic Diseases

13

Shortcast: Epilepsy Phenotype and EEG Finding of RHADS in Succinate Dehydrogenase Deficiency

14

Beyond Triheptanoin: Elamipretide and Cardiolipin Remodelling in TFP Deficiency

15

Shortcast: Treatable Neonatal MoCD Type A: Rapid Demise Despite Rapid Biochemical Diagnosis

16

Personalized metabolic modeling in Methylmalonic Aciduria

17

Shortcast: Holocarboxylase Synthetase Deficiency: Second Case Report With Neonatal Cholestasis

18

Vitamin and Cofactor Prescribing in Primary Mitochondrial Disease

19

Shortcast: Fulminant Metabolic Crisis in GSDIa: Persistent Lactic Acidosis Despite Hypo Correction

20

Palliative care in inherited metabolic disease: an underutilised but essential service

21

Shortcast: A Multisystem Perspective of Pediatric Cell Trafficking Disorders: Within the Cells, Beneath the Signs

22

Manganese transporter disorders: diagnosis and treatment

23

Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants

24

Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff

25

Continuous Glucose Monitoring in hepatic GSDs

26

Metabolic mysteries: Developmental delay, hepatoblastoma and a VUS

27

Biomarkers in Niemann-Pick type C: Preparing for Clinical Trials

28

Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders

29

Chenodeoxycholic acid in Cerebrotendinous Xanthomatosis

30

IMD Research Round-Up: Mitochondrial disease

31

First in human gene editing: a new era for IMD therapies

32

Metabolic mysteries: A 61-year-old with rhabdomyolysis and lifelong episodic fatigue

33

Geriatric IMD: Diagnosing inherited metabolic disorders in older adults

34

IMD Research Round-Up: Untargeted metabolomics

35

Pharmacological chaperones in OTC deficiency

36

Shortcast: Clinical and Developmental Outcomes after 50 Years of Galactosaemia NBS in Ireland

37

Penetrance, expressivity, and outcomes in classic galactosemia

38

IMD Research Round-Up: Lysosomal Storage Disorders

39

Adenosine Kinase

40

Footprints of IMD: Movement Disorders... with Dakota Peacock and Darius Ebrahimi-Fakhari

41

Metabolic mysteries: Incidental adrenal calcifications in a neonate

42

The treatment landscape in CDG

43

IMD Research Round-Up: Newborn Screening

44

ARS1 Deficiencies

45

Shortcast: Investigating the utility of leukocyte sialic acid measurements in Lysosomal FSASD

46

Diagnostic delay in Metachromatic Leukodystrophy

47

IMD Research Round-Up: Glycogen Storage Disorders

48

Future therapies in galactosemia

49

Metabolic mysteries: GI bleeding, gallbladder polyps and evolving developmental delay

50

Speech and Language in Batten disease

51

Metabolic Minds 2025

52

IMD Research Round-Up: Redox metabolism

53

ECHS1 deficiency and valine restriction

54

Metabolic mysteries: A child with episodic seizures and multiple diagnoses

55

Managing Metabolic Emergencies - Intoxication type disorders

56

IEMs in Adult Metabolic Centres: 10 Years Later

57

IMD Research Round-Up: Methylmalonic Aciduria

58

Shortcast: Sleep quality in children with hepatic GSDs, a prospective observational pilot study

59

NAXD deficiency

60

Imaging readiness in the gene therapy era

61

IMD Research Round-Up: Congenital Disorders of Glycosylation

62

Exploring the disease burden in Arginase 1 deficiency

63

Shortcast: D,L-3-hydroxybutyrate in the treatment of glucose transporter 1 deficiency syndrome (Glut1DS)

64

Citrulline: beyond the urea cycle

65

Metabolic mysteries: Hypoglycemia? Don't forget the urine

66

Metabolic mysteries: New weakness, poor balance and paresthesia at 55 years of age

67

Transition & executive function in MSUD

68

Shortcast: TFP deficiency caused by a deep intronic deletion leading to aberrant splicing

69

CBS Deficiency in the E-HOD Registry

70

The Treatabolome: Don't miss the chance to treat!

71

Velmanase alfa for alpha-mannosidosis

72

An update on autophagy disorders

73

Models in Leigh Syndrome

74

KAMPER: Kuvan (BH4) in phenylketonuria

75

Dietary management in GSD type 3a

76

Footprints of IMD: Psychiatric presentations... with Gabriella Horvath

77

Shortcast: Two successful pregnancies in patients taking Volanesorsen for FCS

78

RNA based therapies in Urea Cycle Disorders

79

Brain changes in infantile Pompe disease

80

Shortcast: Metabolic management of a successful pregnancy in FBPase deficiency

81

Gene therapy for mitochondrial disorders

82

Adult outcomes in classic galactosemia

83

Footprints of IMD: Metabolic cardiovascular disease... with Carlos Ferreira

84

Neuronopathic gaucher disease

85

Chorioretinopathy In LCHADD

86

Footprints of IMD: Metabolic myopathies... with Corrado Angelini

87

Flies, plants and classic galactosemia

88

Shortcast: Do early-treated adults with phenylketonuria sense high phenylalanine levels?

89

Fatty acid homeostasis

90

Metabolic mysteries: Progressive neurological symptoms after a change in diet

91

Heterozygous DHDDS variants

92

Footprints of IMD: Metabolic Epilepsies... with Phillip Pearl

93

Gene replacement therapies for inherited disorders of neurotransmission: Progress in SSADH

94

Shortcast: Galactokinase 1 is the source of elevated gal-1-phosphate in a galactosemia mouse model

95

Dietary management for pyridoxine-dependent epilepsy

96

Footprints of IMD: Metabolic Liver Disease... with David Cassiman

97

Shortcast: Normal transferrin glycosylation does not rule out severe ALG1 deficiency

98

Speech & neural oscillation in classic galactosemia

99

Shortcast: Late-onset refractory hemolytic anemia in siblings treated for MTRR deficiency

100

Lessons from adult metabolic medicine

101

Metabolic mysteries: A treatable condition masquerading as TORCH Infection

102

Footprints of IMD: the IEMbase and Cerebral Palsy... with Gabriella Horvath

103

Pregnancy in phenylketonuria

104

Acute liver failure? Think metabolic

105

Aicardi-Goutières syndrome

106

Shortcast: Pediatric palliative care for IMD: 20-year survey of outpatients at a Brazilian hospital

107

Pregnancy in Urea Cycle Disorders

108

Shortcast: Clinical experience with glycerol phenylbutyrate in 20 patients with UCDs

109

Liver directed gene therapy

110

Shortcast: Psychosocial issues and coping strategies in families affected by long-chain FAOD

111

BH4 in tyrosine hydroxylase deficiency

112

Shortcast: Lysinuric protein intolerance exhibiting RTA/Fanconi syndrome in a Japanese woman

113

How to proceed after a "negative" exome

114

Shortcast: Neuropsychological stability in classical galactosemia: A pilot study in 10 adults

115

Food or medicine? Nutritional therapies in IMD

116

Metabolic mysteries: Three children with neurological symptoms and coagulopathy

117

Movement disorders and mRNA therapy in Arginosuccinic aciduria

118

Metabolic mysteries: Recurrent miscarriage and congenital anomalies

119

Hepatic presentations in mitochondrial depletion syndromes

120

Shortcast: Lysosomal storage disorders identified in adult population from India

121

Genomic newborn screening: are we entering a new era of screening?

122

Shortcast: A case of hyperlysinemia identified by urine newborn screening

123

JIMD Editor's Roundtable (2023)

124

Shortcast: Relationship between plasma & capillary blood Phe using volumetric collection devices

125

Deciphering pathogenicity with CRISPR/Cas9

126

Shortcast: Grip strength in patients with galactosemia and in a GALT-null rat model

127

Gene therapy in Glycogen Storage Disorders

128

Shortcast: Screening data for 19 patients with late-onset Pompe disease for a phase I clinical trial

129

CAD deficiency: Beyond the genetics

130

Shortcast: Diagnosis and management of children with McArdle Syndrome (GSD V) in New South Wales

131

Shortcast: PIGO-CDG: A case study, phenotypic expansion, lit review, and nosological considerations

132

Comorbidity in acute porphyria

133

Metabolic mysteries: Post-partum ataxia and confusion

134

Shortcast: A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD

135

An oral enzyme therapy for MSUD

136

Shortcast: Comparison of subcutaneous and intravenous moss-aGal in Fabry disease mouse model

137

Metabolic mysteries: A child with dystonia and MRI changes

138

Fetal gene therapy

139

Shortcast: Interstitial lung disease and pancreatic exocrine insufficiency in CADDS

140

SSIEM 2022 special episode

141

Gene therapy in urea cycle disorders: a historical perspective and future prospects

142

Possible substrate reduction therapy in disorders of valine and isoleucine metabolism

143

Shortcast: Prolonged respiratory failure treatment in isolated homocysteine remethylation defects

144

A clinical severity scoring system for succinic semialdehyde dehydrogenase deficiency

145

Shortcast: Expanding the phenotypic and genotypic spectrum of CARS2-related mitochondrial disease

146

Pregnancy in acute porphyria

147

Gene therapies in mucopolysaccharidoses

148

Shortcast: Neonatal presentation of occipital horn syndrome caused by a ATP7A missense variant

149

Racial diversity and the S135L variant in galactosemia

150

Shortcast: Increased prevalence of Parkinson's disease in alkaptonuria

151

Shortcast: Late infantile & adult-onset MLD due to novel missense variants in the PSAP gene

152

Gene therapy in a mouse model of MSUD

153

Key terms and definitions In porphyria

154

PGM1-CDG: isoforms, phenotyping and gene therapy

155

A novel UHPLC/HRAM MS approach in LSD screening

156

Shortcast: Early treatment of neonatal diabetes with oral glibenclamide in extreme prematurity

157

Cholestasis, oxysterols and clinical conundrums

158

Shortcast: The remarkable journey of one female individual with OTC deficiency diagnosed post-mortem

159

Fractionated plasma N-glycan profiling and ATP6AP1 - CDG

160

Shortcast: Autonomic instability, arrhythmia & visual impairment in MTFMT related mito disease

161

B vitamins, drosophila and TANGO2-deficiency disorder

162

Shortcast: Paracetamol toxicity in classic HCU: Effect of N-acetylcysteine on total homocysteine

163

The complex machinery of cobalamin

164

Shortcast: MOGS-CDG: Quantitative analysis of a diagnostic biomarker & phenotype of 6 new cases

165

How guidelines drive research and research influences guidelines

166

Shortcast: Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency

167

Shortcast: First decade anniversary of the United Kingdom National Alkaptonuria Centre

168

Cellular Insights and Computational Modelling In MMA

169

Novel therapy in a propionic acidemia mouse model

170

Shortcast: Compound heterozygous variants in 2 sialyltransferase ST3GAL5 motifs cause GM3SD

171

Shortcast: 3-Methylglutaconyl-CoA hydratase deficiency: Ascertainment bias vs biochemical diagnosis

172

Priority Setting Partnership in Mitochondrial Disease

173

Shortcast: HPMRS3 (Mabry Syndrome): CSF abnormalities and correction with pyridoxine & Folinic acid

174

Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: 3rd revision

175

Diagnostics, EXPLORE B and POWER in Porphyria

176

Shortcast: Isolated neurological presentations of mevalonate kinase deficiency

177

Novel CSF biomarkers in GLUT1 deficiency syndrome

178

Shortcast: Management of pregnancy in a patient with LCHADD

179

Shortcast: Infantile-onset Pompe disease with neutropenia

180

Sex Specific Screening in X-linked Adrenoleucodystrophy

181

Shortcast: Direct replacement of oral benzoate with glycerol phenylbutyrate in children with UCD

182

Everyone's talking about empagliflozin

183

Shortcast: GA 1: Diagnosis, clinical features & long-term outcome in a cohort of 34 Irish patients

184

Shortcast: Use of Elamipretide in patients assigned treatment in the compassionate use program

185

Genomic Therapies In IMD: Lessons from MMA

186

Shortcast: Transcriptomic study in explanted liver from a patient with acute intermittent porphyria

187

Shortcast: Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III

188

Moving towards management guidelines in ALG8 - CDG

189

Shortcast: Alternative sources of valine and isoleucine for prompt leucine reduction in MSUD

190

Shortcast: N-acetylglutamate synthase deficiency with associated 3-methylglutaconic aciduria

191

Eye movement disorders in Inherited Metabolic Disease

192

Shortcast: The prevalence of inherited metabolic disorders in the Estonian population over 30 years

193

Shortcast: Respiratory chain dysfunction in a patient with a heterozygous de novo CTBP1 variant

194

The doxycycline paradox in mitochondrial disease

195

Training in Adult Metabolic Medicine

196

Shortcast: A cross-sectional natural history study of aspartylglucosaminuria

197

Diagnosis and Discovery: Insights from the Undiagnosed Diseases Program

198

Future Therapies in Galactosaemia

199

Mitochondrial Trifunctional Protein Deficiency

200

Reproductive Genetic Carrier Screening in IMD

201

Glitazones in X-linked adrenoleukodystrophy

202

Betaine in early onset MTHFR Deficiency

203

Shortcast: Clinical spectrum of early onset “Mediterranean” MNGIE

204

Gls2 knockdown - a different approach for Urea Cycle Disorders?

205

Shortcast: Glycogen storage disease type IIIa in pregnant women

206

Lost in translation — Challenges in drug development for rare disease

207

Machine learning in newborn screening

208

Barth Syndrome (part 2): Screening, modelling and more

209

Barth Syndrome (part 1): Disease overview and future treatments

210

CDG or not CDG

211

Shortcast: High penetrance and recurrent attacks in a family with hereditary coproporphyria

212

Dentistry in Inherited Metabolic Disease

213

Shortcast: Very long-chain acyl-CoA dehydrogenase deficiency in a Swedish cohort

214

Shortcast: A serendipitous journey to a promoter variant in OTC

215

NGLY1 deficiency & epilepsy

216

Molybdenum Cofactor Deficiency

217

Shortcast: Chondroitin sulfate disaccharide as a biomarker for MPS IVA

218

Shortcast: A mild phenotype of mitochondrial trifunctional protein deficiency

219

Treatment In Alkaptonuria

220

Shortcast: Acute and early developmental outcomes of children with Duarte galactosemia

221

Arginase Deficiency

222

Shortcast: Two siblings with galactose mutarotase deficiency: Clinical differences

223

AAV-gene therapy in galactosemia patient fibroblasts

224

Unravelling the Secrets Of PMM2-CDG

225

Transplant Outcomes in X-ALD

226

Positive Negatives - genistein and resveratrol

227

100 Years Of IMD (in Austria)

228

Mitochondrial Disease Special Issue: Novel Therapies

229

Organoids in IMD

230

MPS 1: Where are we now?

231

Easy as ABC...D3

232

Assembling the treatment puzzle in Niemann Pick C

233

McArdle disease - expanding the clinical phenotype

234

Gene Therapy in CBS Deficiency

235

Cognitive and psychosocial outcomes in early-treated PKU

236

Disease Or Disorder: New Insights in Valine Degradation

237

Inborn Errors of the Malate Aspartate Shuttle

238

The Young Metabolists Society

239

Why everyone needs to know about Urea Cycle Disorders

240

Treatment In Lysosomal Storage Disorders

241

An International Classification of Inherited Metabolic Disorders

242

Emergency Protocol.net

243

N-glycome analysis in Congenital Disorders of Glycosylation

244

Galactosemia: An old diagnosis with new ideas

245

Diagnosis and management of methylmalonic acidaemia and propionic acidaemia

246

Transplantation in IMD

247

LSD Heterozygosity and Neurodegenerative Disease

248

Everything about Alkaptonuria

249

A narrative review of GSD III

250

ATP6V1A related metabolic cutis laxa

251

All About ALD

252

Pyridoxine-dependent epilepsy

253

Talking about Triheptanoin

254

It takes two to TANGO2

255

Characterising late-onset MTHFR deficiency

256

Best Of JIMD Reports

257

MSD: The diagnosis needs the patients

258

Taking a position on MNGIE

259

Newborn screening: To WES or not to WES

260

Ketogenic diets in inherited metabolic disease

261

Towards Trials in Mitochondrial Disease

262

PGM1-CDG with Professor Morava

263

Simplifying Inherited Metabolic Disease

264

IMD and Susceptibility to COVID19

265

Mitochondria, medication and POLG

266

PKU And Ageing